[go: up one dir, main page]

SE7909392L - Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner - Google Patents

Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner

Info

Publication number
SE7909392L
SE7909392L SE7909392A SE7909392A SE7909392L SE 7909392 L SE7909392 L SE 7909392L SE 7909392 A SE7909392 A SE 7909392A SE 7909392 A SE7909392 A SE 7909392A SE 7909392 L SE7909392 L SE 7909392L
Authority
SE
Sweden
Prior art keywords
aminopyrimidines
imidazolin
hydrogen
carbon atoms
present
Prior art date
Application number
SE7909392A
Other languages
English (en)
Other versions
SE440079B (sv
Inventor
W Stenzel
E Cohnen
W Fleck
B Armah
Original Assignee
Beiersdorf Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from DE2849537A external-priority patent/DE2849537C2/de
Priority claimed from DE19792937023 external-priority patent/DE2937023A1/de
Application filed by Beiersdorf Ag filed Critical Beiersdorf Ag
Publication of SE7909392L publication Critical patent/SE7909392L/sv
Publication of SE440079B publication Critical patent/SE440079B/sv

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/30Halogen atoms or nitro radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/34One oxygen atom
    • C07D239/36One oxygen atom as doubly bound oxygen atom or as unsubstituted hydroxy radical
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/32One oxygen, sulfur or nitrogen atom
    • C07D239/42One nitrogen atom

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SE7909392A 1978-11-15 1979-11-14 Substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner och farmaceutisk komposition SE440079B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE2849537A DE2849537C2 (de) 1978-11-15 1978-11-15 Substituierte 5-(2-Imidazolin-2-yl)-aminopyrimidine, Verfahren zu deren Herstellung und diese enthaltende Arzneimittel
DE19792937023 DE2937023A1 (de) 1979-09-13 1979-09-13 Neue substituierte 5-(2-imidazolin-2-yl)-aminopyrimidine und verfahren zu deren herstellung

Publications (2)

Publication Number Publication Date
SE7909392L true SE7909392L (sv) 1980-05-16
SE440079B SE440079B (sv) 1985-07-15

Family

ID=25776489

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7909392A SE440079B (sv) 1978-11-15 1979-11-14 Substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner och farmaceutisk komposition

Country Status (12)

Country Link
US (1) US4323570A (sv)
AT (1) AT374197B (sv)
AU (1) AU541305B1 (sv)
CA (1) CA1138454A (sv)
CH (1) CH642965A5 (sv)
DK (1) DK150142C (sv)
ES (1) ES486349A1 (sv)
FR (1) FR2441625A1 (sv)
GB (1) GB2039275B (sv)
IT (1) IT1127225B (sv)
NL (2) NL190553C (sv)
SE (1) SE440079B (sv)

Families Citing this family (50)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2146986B (en) * 1983-09-23 1987-06-17 Lilly Co Eli Process for preparing 5-substituted pyrimidines
DE3729299A1 (de) * 1987-09-02 1989-03-23 Beiersdorf Ag Transdermales therapeutisches system
DE3739779A1 (de) * 1987-11-24 1989-06-08 Beiersdorf Ag Pharmazeutische praeparate
DE3904795C2 (de) * 1989-02-17 2000-10-12 Lilly Pharma Produktion Gmbh & Pharmazeutisches Präparat und dessen Verwendung
US5972948A (en) * 1994-07-01 1999-10-26 Solvay Pharmaceuticals Gmbh Method of inhibiting hyperglycemia and pharmaceutical composition for use therein
DE4423177A1 (de) * 1994-07-01 1996-01-04 Kali Chemie Pharma Gmbh Antihyperglykämisch wirksame Arzneimittel
AU4941796A (en) * 1995-02-28 1996-09-18 Beiersdorf-Lilly Gmbh Use of moxonidine for the treatment of atherosclerosis
DE19514579A1 (de) * 1995-04-20 1996-10-24 Boehringer Ingelheim Kg Verwendung von alpha¶1¶¶L¶-Agonisten zur Behandlung der Harninkontinenz
IL118544A (en) * 1995-06-07 2001-08-08 Smithkline Beecham Corp History of imidazole, the process for their preparation and the pharmaceutical preparations containing them
CA2182851A1 (en) * 1995-08-15 1997-02-16 August Masaru Watanabe Method for treating substance abuse withdrawal
ZA974978B (en) * 1996-06-06 1998-12-07 Lilly Co Eli Formulation and method for treating congestive heart failure
ZA981029B (en) * 1997-02-11 1999-08-10 Lilly Co Eli Pharmaceutical agents.
DE19722322A1 (de) * 1997-05-28 1998-12-03 Solvay Pharm Gmbh Nephroprotektives Arzneimittel
AU9302298A (en) * 1997-09-03 1999-03-22 Eli Lilly And Company Pyrimidine derivatives
DE19911371A1 (de) 1999-03-15 2000-09-21 Solvay Pharm Gmbh Arzneimittel zur Behandlung von funktionellen Störungen und Erkrankungen der unteren Darmwege, insbesondere von damit einhergehenden abdominalen visceralen Schmerzen
EP1517688A2 (de) * 2002-06-19 2005-03-30 Solvay Pharmaceuticals GmbH Arzneimittel zur behandlung von eine inhibition oder aktivitätsverminderung von ph-wert-regulierenden bikarbonat-transporter-proteinen erfordernden erkrangungen
BRPI0707308A2 (pt) * 2006-01-27 2011-05-03 Hoffmann La Roche uso de 2-imidazóis para o tratamento de distúrbios do snc
ATE411310T1 (de) * 2006-06-26 2008-10-15 Chemagis Ltd Reinigungsverfahren von moxonidine
EP1894926A1 (en) * 2006-06-26 2008-03-05 Chemagis Ltd. Polymorphs of moxonidine and processes for preparation therefor
ES2369113T3 (es) 2006-06-26 2011-11-25 Chemagis Ltd. Procedimiento mejorado para producir moxonidina.
EP2054391A4 (en) * 2006-08-17 2009-08-26 Chemagis Ltd A SINGLE TAUTOMER-CONTAINING CRYSTALLINE MOXONIDINE AND METHOD FOR THE PRODUCTION THEREOF
DE602006018139D1 (de) * 2006-08-31 2010-12-23 Chemagis Ltd Verwendung der Monoxidinssalze zur Reinigung von Monoxidin
CA2665255A1 (en) * 2006-10-19 2008-04-24 F. Hoffmann-La Roche Ag Aminomethyl-2-imidazoles with affinity with the trace amine associated receptors
BRPI0717939A2 (pt) * 2006-10-19 2013-12-03 Hoffmann La Roche Aminometil-4-imidazóis
BRPI0718054A2 (pt) * 2006-11-02 2013-11-05 Hoffmann La Roche 2-imidazóis substituídos como moduladores de receptores associados à traços de aminas
JP2010510184A (ja) * 2006-11-16 2010-04-02 エフ.ホフマン−ラ ロシュ アーゲー 置換4−イミダゾール類
WO2008073125A1 (en) * 2006-12-12 2008-06-19 Chemagis Ltd. Moxonidine analogs, preparation processes and uses therefor
BRPI0720047A2 (pt) * 2006-12-13 2013-12-24 Hoffmann La Roche 2-imidazóis como ligantes para receptores associados a aminas de traço (taar)
US20080146523A1 (en) * 2006-12-18 2008-06-19 Guido Galley Imidazole derivatives
RU2473545C2 (ru) * 2007-02-02 2013-01-27 Ф.Хоффманн-Ля Рош Аг Новые 2-аминооксазолины в качестве лигандов taar1 для заболеваний цнс
KR101222412B1 (ko) * 2007-02-15 2013-01-15 에프. 호프만-라 로슈 아게 Taar1 리간드로서의 2-아미노옥사졸린
CA2691082A1 (en) 2007-07-02 2009-01-08 F. Hoffmann-La Roche Ag 2 -imidazolines having a good affinity to the trace amine associated receptors (taars)
WO2009003867A1 (en) * 2007-07-03 2009-01-08 F. Hoffmann-La Roche Ag 4-imidazolines and their use as antidepressants
AU2008281918A1 (en) * 2007-07-27 2009-02-05 F. Hoffmann-La Roche Ag 2-azetidinemethaneamines and 2-pyrrolidinemethaneamines as TAAR-ligands
JP2010535172A (ja) * 2007-08-02 2010-11-18 エフ.ホフマン−ラ ロシュ アーゲー Cns障害の処置のためのベンズアミド誘導体の使用
CA2695331A1 (en) * 2007-08-03 2009-02-12 F. Hoffmann-La Roche Ag Pyridinecarboxamide and benzamide derivatives as taar1 ligands
US8242153B2 (en) * 2008-07-24 2012-08-14 Hoffmann-La Roche Inc. 4,5-dihydro-oxazol-2YL derivatives
JP5547187B2 (ja) * 2008-07-24 2014-07-09 エフ.ホフマン−ラ ロシュ アーゲー 4,5−ジヒドロ−オキサゾール−2−イル誘導体
US20100311798A1 (en) * 2009-06-05 2010-12-09 Decoret Guillaume 2-aminooxazolines as taar1 ligands
US8354441B2 (en) * 2009-11-11 2013-01-15 Hoffmann-La Roche Inc. Oxazoline derivatives
US9452980B2 (en) 2009-12-22 2016-09-27 Hoffmann-La Roche Inc. Substituted benzamides
EP2586779A1 (en) 2011-10-24 2013-05-01 Hetero Research Foundation Process for the preparation of moxonidine
DE102012215896A1 (de) * 2012-09-07 2014-03-13 Wörwag Pharma GmbH & Co.KG Moxonidinsynthese mit Hilfe organischer Basen
EP2738165B1 (en) 2012-12-03 2016-10-12 WÖRWAG PHARMA GmbH & Co. KG Method by means of phase transfer catalysis
EP2765131B1 (en) 2013-02-08 2016-11-23 Arevipharma GmbH Process for the production of Moxonidine
CN105121431A (zh) * 2013-03-14 2015-12-02 法尔马克有限公司 用于制造莫索尼定的改进方法
EP2829540A1 (en) 2013-07-26 2015-01-28 Abbott Healthcare Products B.V. Synthesis of substituted aminopyridines
JP6694385B2 (ja) 2013-08-09 2020-05-13 アーデリクス,インコーポレーテッド リン酸塩輸送阻害のための化合物及び方法
SG11201807516UA (en) 2016-03-17 2018-09-27 Hoffmann La Roche 5-ethyl-4-methyl-pyrazole-3-carboxamide derivative having activity as agonist of taar
WO2022101435A1 (en) 2020-11-12 2022-05-19 3Z Ehf Novel treatments of attention deficit/hyperactivity disorder

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE754832A (fr) 1969-08-14 1971-02-15 Beecham Group Ltd Iminazolines
GB1319840A (en) * 1970-08-27 1973-06-13 Beecham Group Ltd Substituted 5-amino imidazoles
BE795636A (fr) * 1972-02-19 1973-08-20 Schering Ag Nitroimidazolylpyrimidines, et leur procede de preparation
US4029792A (en) * 1972-02-29 1977-06-14 Pfizer Inc. (2-Imidazolin-2-ylamino) substituted -quinoxalines and -quinazolines as antihypertensive agents
DE2220906A1 (de) * 1972-04-28 1973-11-15 Boehringer Sohn Ingelheim Neue substituierte 2-phenylaminoimidazoline-(2), deren saeureadditionssalze sowie verfahren zu deren herstellung
BE503170A (sv) * 1975-09-02

Also Published As

Publication number Publication date
ES486349A1 (es) 1980-06-16
DK481879A (da) 1980-05-16
FR2441625A1 (fr) 1980-06-13
DK150142B (da) 1986-12-15
ATA727079A (de) 1983-08-15
CH642965A5 (de) 1984-05-15
GB2039275B (en) 1982-11-17
NL940011I1 (nl) 1994-08-01
NL940011I2 (nl) 1998-05-06
GB2039275A (en) 1980-08-06
DK150142C (da) 1987-06-01
US4323570A (en) 1982-04-06
FR2441625B1 (sv) 1981-12-31
NL7908192A (nl) 1980-05-19
AU541305B1 (en) 1985-01-03
IT1127225B (it) 1986-05-21
IT7927284A0 (it) 1979-11-14
NL190553B (nl) 1993-11-16
CA1138454A (en) 1982-12-28
AT374197B (de) 1984-03-26
SE440079B (sv) 1985-07-15
NL190553C (nl) 1994-04-18

Similar Documents

Publication Publication Date Title
SE7909392L (sv) Nya substituerade 5-(2-imidazolin-2-yl)-aminopyrimidiner
SE7906722L (sv) Merkaptoacylderivat av substituerade proliner
ATE24001T1 (de) Substituierte 1-hydroxyethyl-triazolyl-derivate.
IT1171880B (it) Derivati di 2-ammino-3-acilammino-6-benzilammino-piridina aventi azione antiepilettica e procedimento per la loro produzione
FI880494A (fi) Nya 5-alkoxi-2,4-diaminoalkylbenzener samt dessa innehaollande haorfaergningsmedel.
ATE18768T1 (de) Neue 6-alpha-methylprednisolon-derivate ihre herstellung und verwendung.
PT91575A (pt) Procede de preparation de benzylamines disubstituees utiles comme medicaments
ES2022993B3 (es) Nuevos esteres de acidos ciclopropanocarboxilicos emparentados al acido piretrico, procedimiento de preparacion y aplicacion en la lucha contra los parasitos
ZA816259B (en) 2-(1,4-benzodioxan-2-ylalkyl)imidazoles useful as antidepressants
ATE97899T1 (de) 1,8-benzonaphthyridinderivate, ihre herstellung und diese enthaltende zusammensetzungen.
ZA889023B (en) 2-(piperazinyl)-2-oxoethylene substituted flavonoid derivatives,processes for preparing them and pharmaceutical compositions containing them
IT1196423B (it) Benzotiazolin-composti
SE8502525L (sv) 1,3-oxazolidin-2-on-derivat och forfaranden for framstellning derav
ATE76405T1 (de) 2-trifluormethyl-benzimidazole.
FI843354A (fi) Foerfarande foer framstaellning av nya 4-fenyl-4-oxo-2-ensmoersyraderivat.
ATE13885T1 (de) Phenylpiperazinderivate von hetarylphenolen und hetarylanilinen, ihre herstellung und diese enthaltende therapeutische mittel.
DK384485D0 (da) 1,6-naphthyridinderivater med kardilaterende virkning
DK0452926T3 (da) 5-Aryl-4-alkyl-3H-1,2,4-triazol-3-thioner, der kan anvendes som hukommelsesforbedrende midler
FI803654L (fi) Nya substituerade 2-fenylaminoimidazoliner-(2) deras syraadditionssalter dessa foereningar innehaollande laekemedel och deras framstaellningsfoerfarande
ATE16384T1 (de) Phenylpiperazinyl-propanole von hetarylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ES542393A0 (es) "4-(nitrofenil)-tetrahidropiridinas,procedimiento para su obtencion y su empleo como medicamento"
NO822828L (no) Analogifremgangsmaate ved fremstilling av terapeutisk virksomme 1-fenylindazol-3-on-forbindelser og deres salter
ATE144900T1 (de) Verwendung von xanthinderivaten gegen magengeschwüre
ATE98961T1 (de) 1,8-benzonaphthyridinderivate und ihre herstellung.
NO159380C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive amidazolderivater.

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 7909392-8

SPCF Application for supplementary protection certificate filed

Free format text: 9990012, 981023

SPCG Supplementary protection certificate granted

Free format text: 9990012, 981023, EXPIRES: 20041114

NUG Patent has lapsed

Ref document number: 7909392-8